Tumor suppressor FOXO3 participates in the regulation of intestinal inflammation

This publication has 46 references indexed in Scilit:

• Tumor Suppressor Foxo3a Is Involved in the Regulation of Lipopolysaccharide-Induced Interleukin-8 in Intestinal HT-29 Cells
  Infection and Immunity, 2008
• Independent activation of Akt and NF‐kappaB pathways and their role in resistance to TNF‐α mediated cytotoxicity in gliomas
  Molecular Carcinogenesis, 2007
• NF-κB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145
  Blood, 2006
• Effects of IKK inhibitor PS1145 on NF-κB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells
  Oncogene, 2005
• The AKT/IκB kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-κB and β-catenin
  Oncogene, 2004
• IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a
  Published by Elsevier ,2004
• Neutrophil activation by fMLP regulates FOXO (forkhead) transcription factors by multiple pathways, one of which includes the binding of FOXO to the survival factor Mcl-1
  Journal of Leukocyte Biology, 2003
• NF-κB: a key role in inflammatory diseases
  Journal of Clinical Investigation, 2001
• Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
  Gastroenterology, 1995
• Neutrophil-Activating Peptide (Interleukin-8) in Colonic Mucosa from Patients with Crohn's Disease
  Scandinavian Journal of Gastroenterology, 1993